Prostaglandin E2 induces vascular relaxation by E-prostanoid 4 receptor-mediated activation of endothelial nitric oxide synthase

Hypertension

Volumn 50, Issue 3, 2007, Pages 525-530

  Hristovska, Ana Marija ^a   Rasmussen, Lasse E ^a   Hansen, Pernille B L ^a   Nielsen, Susan S ^a   Nüsing, Rolf M ^b   Narumiya, Shuh ^d   Vanhoutte, Paul ^c   Skøtt, Ole ^a   Jensen, Boye L ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

cGMP; Cyclooxygenase; Hypertension; Phosphorylation; Thromboxane

Indexed keywords

AE 3 208; CALYCULIN A; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC GMP; E PROSTANOID 4 RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANYLATE CYCLASE; GUANYLATE CYCLASE INHIBITOR; N(G) NITROARGININE METHYL ESTER; NIFEDIPINE; PHENYLEPHRINE; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 1C; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PROSTAGLANDIN E2; PROSTANOID RECEPTOR; RECEPTOR BLOCKING AGENT; THREONINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CATHETERIZATION; CONTROLLED STUDY; ENZYME ACTIVATION; HYPERTENSION; HYPOTHESIS; MEASUREMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN TARGETING; VASCULAR ENDOTHELIUM; VASCULAR RING; VASODILATATION; WILD TYPE;

ANIMALS; AORTA; BLOOD PRESSURE; CYCLIC GMP; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; GUANYLATE CYCLASE; MICE; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE III; OSMOLAR CONCENTRATION; PHOSPHORYLATION; RECEPTORS, PROSTAGLANDIN E; SIGNAL TRANSDUCTION; VASODILATION;

EID: 34548150722     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.107.088948     Document Type: Article

References (28)

1. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev. 1999;79:1193-1226.
2. Kennedy CR, Zhang Y, Brandon S, Guan Y, Coffee K, Funk CD, Magnuson MA, Oates JA, Breyer MD, Breyer RM. Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor. Nat Med. 1999;5:217-220.
3. Tilley SL, Audoly LP, Hicks EH, Kim HS, Flannery PJ, Coffman TM, Koller BH. Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor. J Clin Invest. 1999;103:1539-1545.
4. 2. Am J Physiol. 1999;277:H924-H930.
5. Zhang Y, Guan Y, Schneider A, Brandon S, Breyer RM, Breyer MD. Characterization of murine vasopressor and vasodepressor prostaglandin E(2) receptors. Hypertension. 2000;35:1129-1134.
6. Xiao CY, Yuhki K, Hara A, Fujino T, Kuriyama S, Yamada T, Takayama K, Takahata O, Karibe H, Taniguchi T, Narumiya S, Ushikubi F. Prostaglandin E2 protects the heart from ischemia-reperfusion injury via its receptor subtype EP4. Circulation. 2004;109:2462-2468.
7. Nguyen M, Camenisch T, Snouwaert JN, Hicks E, Coffman TM, Anderson PA, Malouf NN, Koller BH. The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth. Nature. 1997;390:78- 81.
8. 2. J Pharmacol Exp Ther. 1999;291:627-633.
9. + channel- and prostaglandin E2-dependent endothelial nitric oxide synthase induction. Circ Res. 2000;87:1149-1156.
10. Zewde T, Mattson DL. Inhibition of cyclooxygenase-2 in the rat renal medulla leads to sodium-sensitive hypertension. Hypertension. 2004;44:424-428.
11. Mattson DL, Lu S, Nakanishi K, Papanek PE, Cowley AW Jr. Effect of chronic renal medullary nitric oxide inhibition on blood pressure. Am J Physiol. 1994;266:H1918-H1926.
12. Braun M, Schror K. Prostaglandin D2 relaxes bovine coronary arteries by endothelium-dependent nitric oxide-mediated cGMP formation. Circ Res. 1992;71:1305-1313.
13. Fujino H, Regan JW. EP4 prostanoid receptor coupling to a pertussis toxin-sensitive inhibitory G protein. Mol Pharmacol. 2006;69:5-10.
14. Gallis B, Corthals GL, Goodlett DR, Ueba H, Kim F, Presnell SR, Figeys D, Harrison DG, Berk BC, Aebersold R, Corson MA. Identification of flow-dependent endothelial nitric-oxide synthase phosphorylation sites by mass spectrometry and regulation of phosphorylation and nitric oxide production by the phosphatidylinositol 3-kinase inhibitor LY294002. J Biol Chem. 1999;274:30101-30108.
15. 2+/calmodulin-dependent endothelial nitric oxide synthase activity. Circ Res. 2001;88:E68-E75.
16. Lin MI, Fulton D, Babbitt R, Fleming I, Busse R, Pritchard KA Jr, Sessa WC. Phosphorylation of threonine 495 in endothelial nitric-oxide synthase coordinates the coupling of L-arginine metabolism to efficient nitric oxide production. J Biol Chem. 2003;278:44719-44726.
17. Mattson DL. Long-term measurement of arterial blood pressure in conscious mice. Am J Physiol. 1998;274:R564-R570.
18. Dorn GW 2nd, Becker MW, Davis MG. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle. J Biol Chem. 1992;267:24897-24905.
19. Michell BJ, Chen Zp, Tiganis T, Stapleton D, Katsis F, Power DA, Sim AT, Kemp BE. Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem. 2001;276:17625-17628.
20. Nishigaki N, Negishi M, Ichikawa A. Two Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the mtetabolic inactivation of the agonist. Mol Pharmacol. 1996;50:1031-1037.
21. 2 receptor EP4 subtype is essential for agonist-induced desensitization. Mol Pharmacol. 1997;51:343-349.
22. Namkoong S, Lee SJ, Kim CK, Kim YM, Chung HT, Lee H, Han JA, Ha KS, Kwon YG, Kim YM. Prostaglandin E2 stimulates angiogenesis by activating the nitric oxide/cGMP pathway in human umbilical vein endothelial cells. Exp Mol Med. 2005;37:588-600.
23. Davis RJ, Murdoch CE, Ali M, Purbrick S, Ravid R, Baxter GS, Tilford N, Sheldrick RL, Clark KL, Coleman RA. EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries. Br J Pharmacol. 2004;141:580-585.
24. Shimokawa H, Yasutake H, Fujii K, Owada MK, Nakaike R, Fukumoto Y, Takayanagi T, Nagao T, Egashira K, Fujishima M, Takeshita A. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol. 1996;28:703-711.
25. 2. Brain Res. 1982;231:335-342.
26. 2 receptor in vivo. Circulation. 2000;101:2833-2840.
27. Fujino T, Yuhki K, Yamada T, Hara A, Takahata O, Okada Y, Xiao CY, Ma H, Karibe H, Iwashima Y, Fukuzawa J, Hasebe N, Kikuchi K, Narumiya S, Ushikubi F. Effects of the prostanoids on the proliferation or hypertrophy of cultured murine aortic smooth muscle cells. Br J Pharmacol. 2002;136:530-539.
28. Kiriyama M, Ushikubi F, Kobayashi T, Hirata M, Sugimoto Y, Narumiya S. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br J Pharmacol. 1997;122:217-224.